Template:Isotope Master: Difference between revisions
Created page with "<h1>[Isotope Name]</h1> =Isotope Basics= Isotope name:<br> Symbol / mass number:<br> Decay mode(s):<br> Decay products:[''include limited discussions on daughter hazards or link out to them'']<br> Physical half-life:<br> Biological half-life:[''include details if the known biological half life is compound specific'']<br> Use Cases:[''include brief discussion or link out to applicable scope of practice page'']<br> =Hazard Characterization= ==Radiological Hazards== Type o..." |
No edit summary |
||
| (7 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
<h1>[Isotope Name]</h1> | <h1>[Isotope Name]</h1> | ||
=Isotope Basics= | =1. Isotope Basics= | ||
Isotope name:<br> | Isotope name:<br> | ||
Symbol / mass number:<br> | Symbol / mass number:<br> | ||
| Line 9: | Line 9: | ||
Biological half-life:[''include details if the known biological half life is compound specific'']<br> | Biological half-life:[''include details if the known biological half life is compound specific'']<br> | ||
Use Cases:[''include brief discussion or link out to applicable scope of practice page'']<br> | Use Cases:[''include brief discussion or link out to applicable scope of practice page'']<br> | ||
=Hazard Characterization= | =2. Hazard Characterization= | ||
==Radiological Hazards== | ==Radiological Hazards== | ||
Type of radiation emitted:<br> | Type of radiation emitted:<br> | ||
| Line 22: | Line 22: | ||
Corrosiveness:<br> | Corrosiveness:<br> | ||
Biological activity: [''e.g., radiopharmaceuticals'']<br> | Biological activity: [''e.g., radiopharmaceuticals'']<br> | ||
=Exposure Pathways= | =3. Exposure Pathways= | ||
External exposure:<br> | External exposure:<br> | ||
Inhalation:<br> | Inhalation:<br> | ||
| Line 28: | Line 28: | ||
Skin contamination / absorption:<br> | Skin contamination / absorption:<br> | ||
Injection / wounds:<br> | Injection / wounds:<br> | ||
=Regulatory & Administrative Controls= | =4. Regulatory & Administrative Controls= | ||
Applicable regulations / licenses:<br> | Applicable regulations / licenses:<br> | ||
Authorized users required:<br> | Authorized users required:<br> | ||
| Line 35: | Line 35: | ||
Posting and labeling requirements:<br> | Posting and labeling requirements:<br> | ||
Record-keeping requirements:<br> | Record-keeping requirements:<br> | ||
=Detection & Monitoring= | =5. Detection & Monitoring= | ||
==Area monitoring<br>== | ==Area monitoring<br>== | ||
Recommended survey instrument(s):<br> | Recommended survey instrument(s):<br> | ||
| Line 47: | Line 47: | ||
Direct survey vs wipe tests:<br> | Direct survey vs wipe tests:<br> | ||
Detection limits and action levels:<br> | Detection limits and action levels:<br> | ||
=ALARA= | =6. ALARA= | ||
==Time== | ==Time== | ||
==Distance== | ==Distance== | ||
| Line 58: | Line 58: | ||
Bremsstrahlung considerations:<br> | Bremsstrahlung considerations:<br> | ||
Shielding for storage vs handling:<br> | Shielding for storage vs handling:<br> | ||
=Handling & Work Practices= | =7. Handling & Work Practices= | ||
Designated work areas:<br> | Designated work areas:<br> | ||
Containment:[''fume hood, glove box, hot cell'']<br> | Containment:[''fume hood, glove box, hot cell'']<br> | ||
| Line 66: | Line 66: | ||
:Eye / face protection:<br> | :Eye / face protection:<br> | ||
Labeling during use:<br> | Labeling during use:<br> | ||
=Storage= | =8. Storage= | ||
Shielded storage container description:<br> | Shielded storage container description:<br> | ||
Secondary containment:<br> | Secondary containment:<br> | ||
| Line 72: | Line 72: | ||
Labeling:[''isotope, activity, date'']<br> | Labeling:[''isotope, activity, date'']<br> | ||
Ventilation requirements:[''if volatile'']<br> | Ventilation requirements:[''if volatile'']<br> | ||
=Transport= | =9. Transport= | ||
Approved containers:<br> | Approved containers:<br> | ||
Shielding during transport:<br> | Shielding during transport:<br> | ||
Labeling and documentation:<br> | Labeling and documentation:<br> | ||
Spill prevention measures:<br> | Spill prevention measures:<br> | ||
=Waste Management= | =10. Waste Management= | ||
Waste type:<br> | Waste type:<br> | ||
Segregation requirements:<br> | Segregation requirements:<br> | ||
| Line 83: | Line 83: | ||
Decay-in-storage criteria:<br> | Decay-in-storage criteria:<br> | ||
Disposal route and documentation:<br> | Disposal route and documentation:<br> | ||
=Decontamination Procedures= | =11. Decontamination Procedures= | ||
Approved cleaning agents:<br> | Approved cleaning agents:<br> | ||
Surface decontamination methods:<br> | Surface decontamination methods:<br> | ||
Verification of decontamination:<br> | Verification of decontamination:<br> | ||
Documentation requirements:<br> | Documentation requirements:<br> | ||
= | =12. Emergency Procedures= | ||
Spills:<br> | Spills:<br> | ||
Personnel contamination:<br> | Personnel contamination:<br> | ||
| Line 98: | Line 98: | ||
:Medical follow-up<br> | :Medical follow-up<br> | ||
:Reporting requirements<br> | :Reporting requirements<br> | ||
=Special Considerations= | =13. Special Considerations= | ||
Volatility:[''e.g., iodine, tritium'']<br> | Volatility:[''e.g., iodine, tritium'']<br> | ||
High-energy gamma emitters:<br> | High-energy gamma emitters:<br> | ||
| Line 104: | Line 104: | ||
Daughter product buildup:<br> | Daughter product buildup:<br> | ||
Activation products:<br> | Activation products:<br> | ||
= | =14. References & Supporting Documents= | ||
Safety data sheets | Safety data sheets:<br> | ||
Regulatory guidance documents:<br> | Regulatory guidance documents:<br> | ||
Institutional SOPs:<br> | Institutional SOPs:<br> | ||
Dosimetry or biokinetic models:<br> | Dosimetry or biokinetic models:<br> | ||
[[Category:Isotopes|999]] | |||
Latest revision as of 20:41, 25 January 2026
[Isotope Name]
1. Isotope Basics
Isotope name:
Symbol / mass number:
Decay mode(s):
Decay products:[include limited discussions on daughter hazards or link out to them]
Physical half-life:
Biological half-life:[include details if the known biological half life is compound specific]
Use Cases:[include brief discussion or link out to applicable scope of practice page]
2. Hazard Characterization
Radiological Hazards
Type of radiation emitted:
Radiation energy(ies):
External exposure risk: [low / moderate / high]
Internal exposure risk: [inhalation, ingestion, absorption]
Critical organs / tissues:
Committed dose concerns:
Non-radiological Hazards
Chemical toxicity:
Volatility / flammability:
Corrosiveness:
Biological activity: [e.g., radiopharmaceuticals]
3. Exposure Pathways
External exposure:
Inhalation:
Ingestion:
Skin contamination / absorption:
Injection / wounds:
4. Regulatory & Administrative Controls
Applicable regulations / licenses:
Authorized users required:
Activity limits per user / room:
Training requirements:
Posting and labeling requirements:
Record-keeping requirements:
5. Detection & Monitoring
Area monitoring
Recommended survey instrument(s):
Detection efficiency for this isotope:
Typical background levels:
Personal monitoring:
Dosimetry:
Bioassay requirements:
Monitoring frequency:
Contamination monitoring
Direct survey vs wipe tests:
Detection limits and action levels:
6. ALARA
Time
Distance
Use of remote handling tools:[tongs, syringe shields, etc.]
Minimum distance precautions:
Shielding
Primary radiation to shield:
Recommended shielding material(s):
Typical thicknesses:
Bremsstrahlung considerations:
Shielding for storage vs handling:
7. Handling & Work Practices
Designated work areas:
Containment:[fume hood, glove box, hot cell]
Personal protective equipment:
- Lab coat:
- Gloves:[type and change frequency]
- Eye / face protection:
Labeling during use:
8. Storage
Shielded storage container description:
Secondary containment:
Security requirements:
Labeling:[isotope, activity, date]
Ventilation requirements:[if volatile]
9. Transport
Approved containers:
Shielding during transport:
Labeling and documentation:
Spill prevention measures:
10. Waste Management
Waste type:
Segregation requirements:
Shielding of waste containers:
Decay-in-storage criteria:
Disposal route and documentation:
11. Decontamination Procedures
Approved cleaning agents:
Surface decontamination methods:
Verification of decontamination:
Documentation requirements:
12. Emergency Procedures
Spills:
Personnel contamination:
- Skin contamination
- Eye exposure
- Internal uptake
Exposure incidents:
- Dose assessment process
- Medical follow-up
- Reporting requirements
13. Special Considerations
Volatility:[e.g., iodine, tritium]
High-energy gamma emitters:
Short half-life operational challenges:
Daughter product buildup:
Activation products:
14. References & Supporting Documents
Safety data sheets:
Regulatory guidance documents:
Institutional SOPs:
Dosimetry or biokinetic models: